InnaMed on Republic

Using smart, at-home blood testing technology to enable personalized medicine.


see other companies in category:

InnaMed Website

minimum raise


maximum raise


start date


stop date


security type


investment minimum


raised to date


reporting date


number of investors


percent of minimum raised


percent of maximum raised


likelihood of reaching max

Likely to Reach Max

dollars per day to reach max


dollars per day committed


dollars per day - category-


dollars per day committed - all companies

More SEC Filing Data on InnaMed from

InnaMed, with a valuation cap of $12 million, is raising crowdfunding on Republic. The company is developing an at-home testing device called TeleLab. The device can be filled with several disease-specific test cartridges and helps to monitor the patients remotely. InnaMed is using modern blood collection techniques, cloud computing, and its patented electrochemical blood analysis technology to provide lab-level testing at home. The company was founded by Eshwar Inapuri, Alan Jernigan, and Anup Singh in May 2016, and has already developed two prototypes. The proceeds of the crowdfunding round, with a minimum target of $50,000 and a maximum target of $1,070,000, will be used for clinical validation and beta testing of the device. InnaMed already has $400,000 in contracts with U.S. government agencies and a top global pharma company.